- Lobbying
- Lobbying by Pharmaceutical Care Management Association
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Joseph Gibson | Chief Minority Counsel, House Judiciary Committee 2007-2008; Chief of Staff, Rep. Lamar Smith 2005-2007; Chief Legislative Counsel & Parliamentarian, House Judiciary Committee 2003-2005; Deputy Asst. Attorney General, Office of Leg. Affairs 2002-2003 Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997 Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997- 2001; Counsel, House Judiciary Committee 1995-1997 |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q4 Report
Termination
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Competition issues in the pharmacy benefit management industry..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate